Name: Global Artemisinine Market Insights, Forecast to 2035
Brand: Extent Research
Price: 3500 USD
Availability: InStock
Rating: 4.7 (263 reviews)

Global Artemisinine Market

Market Size in USD Billion

CAGR : 17.60%

USD 1.14

2025

USD 4.17

2033

Forecast Period	2025 - 2033
Market Size (Base Year)	USD 1.14 Billion
Market Size (Forecast)	USD 4.17 Billion
CAGR	17.60%
Major Market Players	Data provided in full report

The report on global Artemisinine Market scrutinizes majority of the vital aspects of the industry such as market size, market share, market revenue, market trends, and forecast. The report also briefly provides the information regarding competitors and interesting growth opportunities with the help of business strategies opted by the key players of the Artemisinine market. Additionally, this report comprehends the Artemisinine market growth rate through segment analysis including region, application, key players, and type. The regional analysis by Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa, by Product type Extraction from Artemisia annua, Semisynthetic Artemisinine, , by Application Injections, Tablets, Others, , preferably enlightens the readers with necessary growth igniters, opportunities, challenges, and threats for gaining better knowledge regarding the market growth.

Data provided by Extent Research. Source: https://www.extentresearch.com/artemisinine-market

The report most enticingly elaborates the valuable insights into the Artemisinine market approaches and growth after a through market analysis. The research report also talks about the important and dominating factors that are projected to trigger market growth during the forecast period.

Research Objectives:

To analyze the global Artemisinine market by key regions, competitive players, historical and future information, and forecast
To gain better knowledge over the Artemisinine market breakdown structure by studying its various segments
Market analysis depending on the growth trends, future prospects, and other vital contribution
Sharing key factors influencing market growth rate include opportunities, drivers, future scope, industrial challenges, and threats.
To analyze and study regional development status
To study agreements, new product launches, competitive strategies, expansions, and acquisitions in the market
Strategically profiling and analyzing the key players and their business growth strategies

The report lists the major players Guilin Pharmaceutical, CAT KHANH, Novanat Bioresource, BEEPZ, KPC Pharmaceuticals, BIONEXX, Guangxi xiancaotang, Sanofi, Natural Bio-engineering, Kerui nanhai, in the regions and their specific market share based on the global revenue. It also well explains the new product innovations, business strategies, and changing market dynamics. The report provides a cutting edge by providing a complete picture of the market that is anticipated to help investors in their decision making.

Report Scope and Market Segmentation

ATTRIBUTES	Global Artemisinine Market KEY MARKET INSIGHTS
Segments Covered	By Product Type: All Products Type Includes By Application: All Application Type Includes By End User: All End User Type Includes By Distribution Channel: All Distribution Channel Includes
Countries Covered	North America U.S., Canada, Mexico Europe Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe Asia-Pacific China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific Latin America Brazil, Argentina, Rest of Latin America Middle East & Africa Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players	Leading Tier 1 Corporations Prominent Regional Manufacturers Emerging Market Disruptors Technology Integrators & Suppliers *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities	Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability. Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands. Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities. Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry. Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets	In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...

Learn more about Priya M

BASIC ATTRIBUTES \| KEY MARKET INSIGHTS
Report Title	Global Artemisinine Market
Base Year	2025
Forecast Period	2025 - 2033
Market Size (Base)	USD 1.14 Billion
Projected Size	USD 4.17 Billion
CAGR	17.60%

                            1 Study Coverage
    1.1 Artemisinine Product Introduction
    1.2 Market by Type
        1.2.1 Global Artemisinine Market Size Growth Rate by Type, 2017 VS 2021 VS 2035
        1.2.2 Extraction from Artemisia annua
        1.2.3 Semisynthetic Artemisinine
    1.3 Market by Application
        1.3.1 Global Artemisinine Market Size Growth Rate by Application, 2017 VS 2021 VS 2035
        1.3.2 Injections
        1.3.3 Tablets
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Artemisinine Sales Estimates and Forecasts 2017-2035
    2.2 Global Artemisinine Revenue Estimates and Forecasts 2017-2035
    2.3 Global Artemisinine Revenue by Region: 2017 VS 2021 VS 2035
    2.4 Global Artemisinine Sales by Region
        2.4.1 Global Artemisinine Sales by Region (2017-2022)
        2.4.2 Global Sales Artemisinine by Region (2023-2035)
    2.5 Global Artemisinine Revenue by Region
        2.5.1 Global Artemisinine Revenue by Region (2017-2022)
        2.5.2 Global Artemisinine Revenue by Region (2023-2035)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Artemisinine Sales by Manufacturers
        3.1.1 Global Top Artemisinine Manufacturers by Sales (2017-2022)
        3.1.2 Global Artemisinine Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Artemisinine in 2021
    3.2 Global Artemisinine Revenue by Manufacturers
        3.2.1 Global Artemisinine Revenue by Manufacturers (2017-2022)
        3.2.2 Global Artemisinine Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Artemisinine Revenue in 2021
    3.3 Global Artemisinine Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Artemisinine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Artemisinine Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Artemisinine Sales by Type
        4.1.1 Global Artemisinine Historical Sales by Type (2017-2022)
        4.1.2 Global Artemisinine Forecasted Sales by Type (2023-2035)
        4.1.3 Global Artemisinine Sales Market Share by Type (2017-2035)
    4.2 Global Artemisinine Revenue by Type
        4.2.1 Global Artemisinine Historical Revenue by Type (2017-2022)
        4.2.2 Global Artemisinine Forecasted Revenue by Type (2023-2035)
        4.2.3 Global Artemisinine Revenue Market Share by Type (2017-2035)
    4.3 Global Artemisinine Price by Type
        4.3.1 Global Artemisinine Price by Type (2017-2022)
        4.3.2 Global Artemisinine Price Forecast by Type (2023-2035)
5 Market Size by Application
    5.1 Global Artemisinine Sales by Application
        5.1.1 Global Artemisinine Historical Sales by Application (2017-2022)
        5.1.2 Global Artemisinine Forecasted Sales by Application (2023-2035)
        5.1.3 Global Artemisinine Sales Market Share by Application (2017-2035)
    5.2 Global Artemisinine Revenue by Application
        5.2.1 Global Artemisinine Historical Revenue by Application (2017-2022)
        5.2.2 Global Artemisinine Forecasted Revenue by Application (2023-2035)
        5.2.3 Global Artemisinine Revenue Market Share by Application (2017-2035)
    5.3 Global Artemisinine Price by Application
        5.3.1 Global Artemisinine Price by Application (2017-2022)
        5.3.2 Global Artemisinine Price Forecast by Application (2023-2035)
6 North America
    6.1 North America Artemisinine Market Size by Type
        6.1.1 North America Artemisinine Sales by Type (2017-2035)
        6.1.2 North America Artemisinine Revenue by Type (2017-2035)
    6.2 North America Artemisinine Market Size by Application
        6.2.1 North America Artemisinine Sales by Application (2017-2035)
        6.2.2 North America Artemisinine Revenue by Application (2017-2035)
    6.3 North America Artemisinine Market Size by Country
        6.3.1 North America Artemisinine Sales by Country (2017-2035)
        6.3.2 North America Artemisinine Revenue by Country (2017-2035)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Artemisinine Market Size by Type
        7.1.1 Europe Artemisinine Sales by Type (2017-2035)
        7.1.2 Europe Artemisinine Revenue by Type (2017-2035)
    7.2 Europe Artemisinine Market Size by Application
        7.2.1 Europe Artemisinine Sales by Application (2017-2035)
        7.2.2 Europe Artemisinine Revenue by Application (2017-2035)
    7.3 Europe Artemisinine Market Size by Country
        7.3.1 Europe Artemisinine Sales by Country (2017-2035)
        7.3.2 Europe Artemisinine Revenue by Country (2017-2035)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Artemisinine Market Size by Type
        8.1.1 Asia Pacific Artemisinine Sales by Type (2017-2035)
        8.1.2 Asia Pacific Artemisinine Revenue by Type (2017-2035)
    8.2 Asia Pacific Artemisinine Market Size by Application
        8.2.1 Asia Pacific Artemisinine Sales by Application (2017-2035)
        8.2.2 Asia Pacific Artemisinine Revenue by Application (2017-2035)
    8.3 Asia Pacific Artemisinine Market Size by Region
        8.3.1 Asia Pacific Artemisinine Sales by Region (2017-2035)
        8.3.2 Asia Pacific Artemisinine Revenue by Region (2017-2035)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Artemisinine Market Size by Type
        9.1.1 Latin America Artemisinine Sales by Type (2017-2035)
        9.1.2 Latin America Artemisinine Revenue by Type (2017-2035)
    9.2 Latin America Artemisinine Market Size by Application
        9.2.1 Latin America Artemisinine Sales by Application (2017-2035)
        9.2.2 Latin America Artemisinine Revenue by Application (2017-2035)
    9.3 Latin America Artemisinine Market Size by Country
        9.3.1 Latin America Artemisinine Sales by Country (2017-2035)
        9.3.2 Latin America Artemisinine Revenue by Country (2017-2035)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Artemisinine Market Size by Type
        10.1.1 Middle East and Africa Artemisinine Sales by Type (2017-2035)
        10.1.2 Middle East and Africa Artemisinine Revenue by Type (2017-2035)
    10.2 Middle East and Africa Artemisinine Market Size by Application
        10.2.1 Middle East and Africa Artemisinine Sales by Application (2017-2035)
        10.2.2 Middle East and Africa Artemisinine Revenue by Application (2017-2035)
    10.3 Middle East and Africa Artemisinine Market Size by Country
        10.3.1 Middle East and Africa Artemisinine Sales by Country (2017-2035)
        10.3.2 Middle East and Africa Artemisinine Revenue by Country (2017-2035)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Guilin Pharmaceutical
        11.1.1 Guilin Pharmaceutical Corporation Information
        11.1.2 Guilin Pharmaceutical Overview
        11.1.3 Guilin Pharmaceutical Artemisinine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Guilin Pharmaceutical Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Guilin Pharmaceutical Recent Developments
    11.2 CAT KHANH
        11.2.1 CAT KHANH Corporation Information
        11.2.2 CAT KHANH Overview
        11.2.3 CAT KHANH Artemisinine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 CAT KHANH Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 CAT KHANH Recent Developments
    11.3 Novanat Bioresource
        11.3.1 Novanat Bioresource Corporation Information
        11.3.2 Novanat Bioresource Overview
        11.3.3 Novanat Bioresource Artemisinine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Novanat Bioresource Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Novanat Bioresource Recent Developments
    11.4 BEEPZ
        11.4.1 BEEPZ Corporation Information
        11.4.2 BEEPZ Overview
        11.4.3 BEEPZ Artemisinine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 BEEPZ Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 BEEPZ Recent Developments
    11.5 KPC Pharmaceuticals
        11.5.1 KPC Pharmaceuticals Corporation Information
        11.5.2 KPC Pharmaceuticals Overview
        11.5.3 KPC Pharmaceuticals Artemisinine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 KPC Pharmaceuticals Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 KPC Pharmaceuticals Recent Developments
    11.6 BIONEXX
        11.6.1 BIONEXX Corporation Information
        11.6.2 BIONEXX Overview
        11.6.3 BIONEXX Artemisinine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 BIONEXX Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 BIONEXX Recent Developments
    11.7 Guangxi xiancaotang
        11.7.1 Guangxi xiancaotang Corporation Information
        11.7.2 Guangxi xiancaotang Overview
        11.7.3 Guangxi xiancaotang Artemisinine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Guangxi xiancaotang Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Guangxi xiancaotang Recent Developments
    11.8 Sanofi
        11.8.1 Sanofi Corporation Information
        11.8.2 Sanofi Overview
        11.8.3 Sanofi Artemisinine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Sanofi Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Sanofi Recent Developments
    11.9 Natural Bio-engineering
        11.9.1 Natural Bio-engineering Corporation Information
        11.9.2 Natural Bio-engineering Overview
        11.9.3 Natural Bio-engineering Artemisinine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Natural Bio-engineering Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Natural Bio-engineering Recent Developments
    11.10 Kerui nanhai
        11.10.1 Kerui nanhai Corporation Information
        11.10.2 Kerui nanhai Overview
        11.10.3 Kerui nanhai Artemisinine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Kerui nanhai Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Kerui nanhai Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Artemisinine Industry Chain Analysis
    12.2 Artemisinine Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Artemisinine Production Mode & Process
    12.4 Artemisinine Sales and Marketing
        12.4.1 Artemisinine Sales Channels
        12.4.2 Artemisinine Distributors
    12.5 Artemisinine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Artemisinine Industry Trends
    13.2 Artemisinine Market Drivers
    13.3 Artemisinine Market Challenges
    13.4 Artemisinine Market Restraints
14 Key Findings in The Global Artemisinine Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer                        

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst

Global Artemisinine Market